Skip to main content

Guaifenesin and Pseudoephedrine HCl

NDC 58602-834 · Aurohealth LLC

Generic nameGuaifenesin and Pseudoephedrine HCl
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE
Strength1200; 120 mg/1; mg/1
Pharmacologic classAdrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]
Marketing categoryANDA

Packages

58602-834-77 — 1 BLISTER PACK in 1 CARTON (58602-834-77) / 12 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

58602-834-78 — 2 BLISTER PACK in 1 CARTON (58602-834-78) / 12 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

58602-803 — Ibuprofen and Pseudoephedrine HCl, 58602-804 — Pseudoephedrine HCl, 58602-807 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 58602-810 — Guaifenesin, 58602-811 — Guaifenesin, 58602-816 — Naproxen Sodium and Pseudoephedrine Hydrochloride, 58602-824 — Guaifenesin and Dextromethorphan HBr, 58602-825 — Guaifenesin and Dextromethorphan HBr, 58602-832 — Naproxen Sodium and Pseudoephedrine Hydrochloride, 58602-833 — Guaifenesin and Pseudoephedrine HCl, 58602-839 — Ibuprofen and Pseudoephedrine Hydrochloride, 58602-844 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 58602-849 — Guaifenesin and Dextromethorphan HBr, 58602-853 — Guaifenesin, 58602-857 — Guaifenesin, 58602-864 — Guaifenesin, 58602-865 — Guaifenesin, 58602-871 — Guaifenesin and Dextromethorphan HBr, 58602-884 — pseudoephedrine hydrochloride, 58657-500 — Codeine Phosphate and Guaifenesin, +1673 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels